Product Information
NICOTINE 4 MG CHEWING GUM is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2866 per EA under NDC 57237032350. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Dec 29, 2008.
Strength
4 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237032350
Classification
Generic
Dosage Form
GUM, CHEWING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA078697FDA Approved
12/29/2008
On Market Since
8/10/2023
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 4 MG CHEWING GUM has been published 32 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2866 per EA |
|---|---|
| All-time high | $0.2866 (Sep 30, 2026) |
| All-time low | $0.2788 (Apr 22, 2026) |
| 52-week high | $0.2866 |
| 52-week low | $0.2788 |
| Median price | $0.2817 |
| Average price | $0.2820 |
| Largest weekly change | +2.1% (Jul 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICOTINE 4 MG CHEWING GUM?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG CHEWING GUM, manufactured by Rising Pharma Holdings Inc., is $0.2866 per EA (NDC 57237032350), effective Sep 30, 2026.
How has the price of NICOTINE 4 MG CHEWING GUM changed over time?
Over the history we have for it, the NADAC for NICOTINE 4 MG CHEWING GUM has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG CHEWING GUM?
Since Feb 25, 2026, the NADAC for NICOTINE 4 MG CHEWING GUM has ranged from a low of $0.2788 (Apr 22, 2026) to a high of $0.2866 (Sep 30, 2026), with a median of $0.2817 per EA.
Are there cheaper alternatives to NICOTINE 4 MG CHEWING GUM?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICOTINE 4 MG CHEWING GUM, is $0.2323 per EA — about 19% below NICOTINE 4 MG CHEWING GUM.
Who manufactures NICOTINE 4 MG CHEWING GUM?
NICOTINE 4 MG CHEWING GUM (NDC 57237032350) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.